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Abstract 
The dose-response effect refers to the relationship between the dose (e.g., length, frequency) 
of treatment and the subsequent probability of improvement. This systematic review aimed to  
synthesise the literature on the dose-response effect in routine psychological therapies 
delivered to adult patients with mental health problems. Twenty-six studies were eligible for 
inclusion. Different methodological approaches have been used to examine the dose-response 
effect; including survival analysis, multilevel modelling and descriptive cluster analyses. 
Replicated and consistent support was found for a curvilinear (log-linear or cubic) relationship 
between treatment length and outcomes, with few exceptions such as eating disorders and 
severe psychiatric populations. Optimal doses of psychotherapy in routine settings range 
between 4 ± 26 sessions (4 ± 6 for low intensity guided self-help) and vary according to setting, 
clinical population and outcome measures. Weekly therapy appears to accelerate the rate of 
improvement compared to less frequent schedules. Most of the reviewed evidence is from 
university counselling centres and outpatient psychotherapy clinics for common mental health 
problems. There is scarce and inconclusive evidence in clinical samples with chronic and 
severe mental disorders.  
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Introduction 
The expression ³GRVH-UHVSRQVH´LVGHULYHGIURPWKHSKDUPDFRORJLFDOOLWHUDWXUHDQGUHIHUVWR
the relationship between the dose (e.g., quantity and/or concentration) of a treatment and the 
subsequent probability of improvement. ,QDSV\FKRWKHUDS\FRQWH[W³GRVH´commonly refers 
to the number of therapy sessions delivered, DQG³UHVSRQVH´ refers to evidence of clinically 
and/or statistically defined improvement. In a seminal study, Howard, Kopta, Krause and 
Orlinsky (1986) first examined the dose-response effect in psychotherapy using data from 
2,431 cases across 15 studies. Three important observations were derived from this work. First, 
the relationship between the number of sessions and treatment outcome conforms to a log-
linear function (a negatively accelerating or curvilinear trend). Second, most of the therapeutic 
change occurs during the earlier sessions of treatment (usually by session 8). Third, this 
curvilinear relationship predicts diminishing improvements over time. Based on these 
observations, an ³optimal dose of therapy´ could be defined as an interval, between the point 
at which at least 50% of treatment responders are detected, and the point after which response 
rates plateau (no further improvements observed with additional sessions). The rationale for 
the 50% response rule is based on the notion that the majority of treatment responders are 
identified by this point, and the remaining cases have an increasingly low (<50%) probability 
of improvement thereafter. 
Since Howard DQG FROOHDJXHV¶ pioneering work, several studies have examined the 
dose-response effect in randomised controlled trials (e.g., Barkham et al., 1996) and naturalistic 
settings (e.g., Hansen, Lambert, & Forman, 2002). Methods used in these studies include 
survival analysis (e.g. Anderson & Lambert, 2001; Hansen & Lambert, 2003), longitudinal 
multilevel modelling (e.g., Baldwin, Berkeljon, Atkins, Olsen, & Nielsen, 2009; Reese, 
Toland, & Hopkins, 2011), logistic regression (e.g., Baldwin et al., 2009; Erekson, Lambert, 
& Eggett, 2015), cumulative dose-response curves (e.g., Callahan and Hynan, 2005; Delgadillo 
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et al., 2016) and other descriptive methods. Furthermore, outcome definitions vary across 
studies, including estimations of clinically significant and/or statistically reliable improvement 
as proposed by Jacobson and Truax (1991). The dose-response literature is characterised by 
studies with diverse methodological approaches, patient diagnoses, psychotherapies, outcome 
measures used, and criteria applied to define improvement. Consequently, inconsistent 
³RSWLPDOGRVH´UHFRPmendations have been proposed in different studies. For example, some 
studies in university counselling centres (UCCs) suggest an optimal dose around 8 ± 11 
sessions (Anderson & Lambert, 2001; Baldwin et al., 2009), whilst other studies in UCCs 
recommend 4 ± 10 sessions (Draper et al., 2002). Similar discrepancies are found in studies 
with primary care clinical samples, where some recommend between 4 ± 6 sessions (Delgadillo 
et al., 2014, 2016) and others recommend 8 ± 13 sessions (Falkenstrom et al., 2016).  
Several studies have suggested that an alternative perspective, the good-enough level 
(GEL) model, better represents the nature of patient response to psychotherapy (Baldwin et al., 
2009; Barkham et al., 1996, 2006; Falkenstrom et al., 2016; Owen et al., 2016; Reese et al., 
2011; Stiles et al., 2008, 2015). According to the GEL model, patients who attend different 
lengths of treatment change at different rates; some respond quickly within a few sessions while 
others respond gradually with longer treatments. In contrast to the dose-response model, the 
GEL model proposes that the effect of additional sessions is not (on average) equal across 
people, and therefore the duration of therapy is unrelated to the probability of improvement or 
negatively related in samples with a large proportion of rapid responders (Barkham et al., 
2006). Thus, there are key theoretical distinctions between these alternative models. The dose-
response model assumes that exposure to longer treatments causes symptomatic improvements 
in a similar way across patients, but the strength of each additional session weakens over time. 
While the GEL model assumes that differential treatment durations reflect the extent to which 
subgroups of patients are responsive to therapy, where longer treatments are a proxy marker 
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for more difficult-to-treat subgroups. Within the GEL literature, there is mixed evidence 
regarding the extent to which dose-outcome relationships within subgroups of cases with 
similar durations of treatment may be linear or curvilinear (Barkham et al., 2006; Baldwin et 
al., 2009; Reese et al., 2011; Stiles et al., 2008, 2015). 
Given this highly heterogeneous literature, the clinical and organisational implications 
are unclear. The present systematic review therefore had two objectives; the first 
methodological and the second practical. The first objective was to summarise the 
methodologies used to explore the relationship between treatment duration and outcomes, in 
order to understand how the findings may be related to the choice of methods.  The second 
objective was to assess if the current evidence could glean a clear indication of an optimal dose 
of psychotherapy in routine care, and to define any differences in the optimal length of 
treatment for different clinical settings or psychotherapies. 
[Figure 1] 
Methods 
Protocol and registration 
A systematic review protocol was published prospectively in the PROSPERO database. 
[http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018088886].  
Search strategy and study selection  
The following databases were searched (1946 to present): PsychInfo, Scopus, and MEDLINE 
(including Epub ahead of print, in-process and other non-indexed citations). Key search terms 
were combined using Boolean operators (AND, OR), and included different synonyms of the 
terms: dose, length, duration, psychotherapy, outcome, and response.  Following the database 
searches, reference lists of studies eligible for inclusion were hand searched and a forward 
citations were searched using Google Scholar. Any full texts that could not be sourced were 
requested by contacting authors.  In order to address the objectives of the review, the search 
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focused on identifying studies which made explicit reference to, and attempted to study, the 
dose-response effect.  
Inclusion and exclusion criteria  
Studies eligible for inclusion included (1) adults aged 16 and over; (2) patients with 
psychological disorders and symptoms, receiving routinely delivered therapies; (3) using 
validated clinical outcome measures.  We excluded (1) studies which randomised or allocated 
participants to treatment conditions; and (2) studies which explored extensions of the dose-
response relationship such as the phase model, without reference to dose-response.   
The rationale for only reviewing naturalistic studies was two-fold. First, routine care 
studies often allow variable treatment durations, unlike controlled trials which commonly 
stipulate minimum and maximum treatment durations (thus limiting the possibility of studying 
the dose-response effect in variable-length treatments). Second, we chose to study naturalistic 
samples in order to derive findings that were generalizable and most directly informative for 
routine psychological care.  Figure 2 details the selection process which resulted in the studies 
eligible for inclusion. 
[Figure 2] 
Data Extraction  
Data from eligible studies were collected using a standardised data extraction form. Study 
characteristics including patient demographics, symptoms and diagnoses, interventions, study 
settings, primary outcome measures and methodological approaches were the key details 
extracted, along with findings on the optimal dose and nature of the dose-response effect. 
Quality Assessment 
All studies eligible for inclusion were assessed using the 12-item CASP checklist for cohort 
studies (Critical Appraisal Skills Programme, 2018). (DFKTXHVWLRQUHTXLUHV³\HV´³FDQ¶WWHOO´
RU³QR´DQVZHUVZKLFKZHUHWKHQVXEsequently assigned scores of 1, 0 and 0, respectively. A 
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total score was calculated for each study, out of a maximum of 12 points, where scores <6 are 
indicative of below average quality. The full set of studies were quality-assessed by the first 
author, with a random selection of 50% of the studies independently rated by a second assessor. 
The interrater reliability for this subset of studies was Kappa = 0.865, indicating good 
agreement.  
Data analysis 
A narrative synthesis of the findings was planned a priori, in line with the study objectives, 
grouping findings by the methods used to study the dose-response effect, followed by a 
breakdown of the findings by patient groups, therapies and any other relevant groupings 
identified. 
[Table 1] 
Results 
Overview of included studies 
In total, 26 studies met the criteria for inclusion (see Table 1 for a summary), revealing high 
heterogeneity in terms of setting, patient group and outcome measures used.  More than half of 
these studies (n = 14) were conducted in University training centres or UCCs, while the rest 
were conducted in primary care, specialist psychotherapy services or in private practice. The 
majority of studies included patient samples presenting with multiple diagnoses (mixed), 
receiving a range of therapies. Six studies did not specify the diagnoses or presenting problems 
that were being treated and ten studies gave little (or no) information regarding what 
psychotherapies were delivered.   
The majority of studies (n = 21) used a single outcome measure. The Outcome 
Questionnaire (OQ-45; Lambert et al., 1996) was used in 11 studies; four used the Behavioural 
Health Measure (BHM-20; Kopta & Lowry, 2002), three used the Clinical Outcomes in 
Routine Evaluation Outcome Measure (CORE-OM; Barkham, Gilbert, Connell, Marshall, & 
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Twigg, 2005; Evans et al., 2002), one used the Eating Disorders Examination Questionnaire 
(EDE-Q; Fairburn & Beglin, 1994), one used the Revised Symptom Checklist (SCL-90-R; 
Derogatis, 1983), and one used the German Questionnaire for the Evaluation of 
Psychotherapeutic Change Processes (FEP; Lutz et al., 2009). The remaining five studies 
applied multiple outcome measures (Beail, Kellett, Newman, & Warden, 2007; Delgadillo et 
al., 2014, 2016; Lincoln, Jung, Weisjahn, & Schlier, 2016; Snell, Mallinckrodt, Hill, & 
Lambert, 2001). In terms of how change was defined, most studies used a conventional 
definition of reliable change (RC) or reliable and clinically significant improvement (RCSI), 
based on the criteria proposed by Jacobson and Truax (1991). However, many different 
combinations and operationalisations of these criteria were used (see Table 2 for a summary). 
[Table 2] 
Quality assessment  
All included studies scored 5 and above out of 12 on the CASP checklist. Quality assessment 
scores for each of the included studies are presented in Table 1 and detailed in a supplementary 
appendix. Study quality was seen to vary across studies and no apparent pattern of dose-
response recommendations was evident according to quality ratings. Only five studies were 
found to adequately adjust for all potential confounding factors. 
Methodological approaches to studying the dose-response effect 
Kaplan-Meier procedure. Six studies applied survival analysis, following the Kaplan-
Meier procedure  to predict the number of sessions required to attain RC or RCSI (Anderson 
& Lambert, 2001; Asay, Lambert, Gregersen, & Goates, 2002; Carr, Saules, Koch, & Waltz, 
 +DUQHWW 2¶'RQRYDQ 	 /DPEHUW  6QHOO HW DO  :ROJDVW /DPEHUW 	
Puschner, 2003). Cox regression was used in conjunction with survival analysis in two studies, 
adjusting for pre-treatment symptom severity (Asay et al., 2002; Snell et al., 2001). 
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Results indicated that for 50% of patients to reach RC, between 7 ± 42 sessions were 
required. For 50% of patients to reach RCSI, 11 ± 54 sessions were estimated.  This large 
discrepancy can be mostly attributed to the study by Asay et al. (2002). This study predicted 
42 and 54 sessions for 50% probability of RC or RCSI, respectively. Specific characteristics 
RIWKLVVWXG\PRVWOLNHO\FDXVHUHVXOWVWRGLIIHURQO\DVLQJOHWKHUDSLVW¶VFRKRUWRISDWLHQWVwas 
used in the study sample, 66% of patients presented with comorbid axis II personality disorders, 
and no session limits were imposed in this clinic. Lengthier estimates were also derived by 
Snell et al. (2001); they measured outcomes at an approximate 10-month follow-up and found 
that the probability of 50% of patients achieving and maintaining RC and RCSI post-
termination of therapy, was observed at 14 and 16 sessions, respectively.   
The five studies from training clinics are largely homogenous in their sample 
characteristics. Collectively, they suggest that between 7 ± 14 sessions were required for 50% 
to reach RC and between 11 ± 19 sessions were required for 50% to reach RCSI.  Three of 
these studies measured outcomes on a session-by-session basis and utilised the full dataset by 
extracting the first point at which a patient reaches RC or RCSI, which then needed to be 
maintained until termination of treatment without backsliding (Anderson & Lambert, 2001; 
Harnett et al., 2010; Wolgast et al., 2003). Findings from these three studies indicate that 8 (n 
= 1 study) to 10 (n = 2) sessions were required for 50% RC, and 11 (n = 1) to 14 (n = 2) sessions 
for 50% RCSI.  
Recovery tables. Only one study used survival analysis in the form of recovery tables 
to estimate the treatment length required for the first observation of RCSI to be maintained 
until follow-up (Kadera et al., 1996). Recovery tables indicated that 44% of cases would reach 
RCSI in 13 sessions, and 50% by session 16.  Across studies using survival analysis, estimates 
IRURSWLPDOGRVHEDVHGRQSDWLHQWV¶ILUVWREVHUYDWLRQRI5&UDQJHEHWZHHQ-13 sessions, and 
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between 11-16 sessions for RCSI. Lengthier doses are observed in patients with more complex 
presentations (e.g., psychosis) or to maintain improvement until a 10-month follow-up point. 
Logistic regression. Logistic or multilevel logistic regression was used in three studies.  
Baldwin et al. (2009) used logistic regression to estimate the number of sessions required to 
reach RCSI. The probability of RCSI increased until 8 sessions, with no further improvements 
beyond this point. Lincoln et al. (2016) mirrored this method, but to specifically examine the 
dose-response effect in CBT for psychosis. A minimum of 15 sessions was required for the 
first significant reduction in symptoms, however, based on subsequent diminishing gains, 20 ± 
30 sessions was suggested as the optimal dose. Erekson et al. (2015) used multilevel logistic 
regression to examine if session frequency predicted the likelihood of RCSI. Overall, the 
results indicated that the probability of achieving RCSI or RC were equal regardless of whether 
treatment was weekly or fortnightly, with more sessions required for equivalent outcomes in 
fortnightly therapy.   
Probit analysis. Probit analysis was used in one study (Kopta et al., 1994) to examine 
the dose-response effect in a poly-symptomatic sample, grouping symptoms into three latent 
classes: acute, chronic and characterological. Findings indicated that the median number of 
sessions for acute symptoms to reach RCSI was 5; 14 sessions was estimated for chronic 
symptoms; and for characterological symptoms, less than 50% of patients reached RCSI by the 
end of 52 sessions. Across the most commonly measured symptoms, 50% of patients were 
expected to reach RCSI by 11 sessions.  
Analysis of variance. Analysis of variance (ANOVA) methods were used in three 
studies. Beail et al. (2007) studied a sample of individuals with intellectual disabilities, being 
treated for mental health problems with open-ended psychodynamic psychotherapy. ANOVA 
was used to test for significant differences in pre-post treatment effect sizes between groups 
that received different lengths of therapy. No significant differences between 8, 16 and 24 
11 
 
weeks of therapy were observed, suggesting that minimal (or no) gains were observed beyond 
8 sessions of psychodynamic therapy for patients with intellectual disabilities. Kopta et al. 
(2014) also used ANOVA to examine differences in pre-post change scores between groups of 
patients across 23 UCCs, categorised by total lengths of therapy. Post-hoc analyses revealed 
that longer treatments were associated with greater change scores until 7 ± 10 sessions, but 
smaller and non-significant gains were observed beyond this point. Bell, Waller, Shafran and 
Delgadillo (2016) found no evidence of a typical curvilinear or linear dose-response association 
between treatment duration and EDE-Q scores in a sample of outpatients with eating disorders, 
but patients who showed early improvements (by session 8) were significantly more likely to 
attain post-treatment RCSI. 
Cumulative dose-response curves. Cumulative response-rate curves of patients 
reaching clinical significance criteria were presented in three studies (Callahan and Hynan, 
2005; Delgadillo et al., 2016; Kadera et al., 1996). Comparisons between each of these studies 
are limited primarily by differences in the restrictiveness of the sampling of patient groups (i.e. 
full sample, dysfunctional only or those who achieve RCSI), by the outcome criteria of interest 
and also by the total number of sessions examined in the study (e.g., a maximum of 9 sessions 
was plotted in the study by Delgadillo et al., 2016, compared to other studies examining time-
unlimited therapies). A common trend was for steep initial recovery curves with diminishing 
gains in the latter stages of therapy; the point of inflexion occurring between 4 ± 24 sessions.  
RCSI rates stratified by total treatment sessions. Percentages of patients achieving RC 
and RCSI stratified by the total number of sessions attended were reported in five studies 
(Draper et al., 2002; Delgadillo et al., 2016; Delgadillo et al., 2014; Kopta et al, 2014; Snell et 
al., 2001). In contrast to cumulative percentages, stratified percentages represent the proportion 
of patients terminating in that range of sessions only, rather than a percentage of the full sample. 
Within these studies, a minimum of four (Draper et al., 2002; Delgadillo et al., 2014) and a 
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maximum of 8 ± 12 sessions (Snell et al., 2001) was suggested as the optimal dose. However, 
whilst some studies found a clear indication of an optimal dose (Delgadillo et al., 2014, 2016; 
Kopta et al., 2014) others demonstrated that using this method yielded unclear findings, marked 
by fluctuations in patient recovery rates over the duration of therapy (Draper et al., 2002; Snell 
et al., 2001). Such seemingly random fluctuations of response rates in subgroups of cases with 
the same number of treatment sessions may well be explained by small sample sizes (e.g. under 
100 cases) in each subgroup. 
Correlations. Correlational analyses were used in three studies to examine the 
relationship between the percentage of patients recovered and total duration of therapy. 
Specifically pertaining to RCSI rates stratified by total sessions within these studies, Stiles, 
Barkham, Connell, & Mellor-Clark (2008) and Stiles et al. (2015), found a negative overall 
relationship between RCSI rates and treatment duration. The earlier study found this 
exclusively in UK primary care settings and the latter replicated this across a range of settings 
including primary and secondary care settings and UCCs, however this relationship was not 
observed in voluntary and work place sectors. Overall, the negative relationship between 
treatment dose and outcome was taken as evidence contrary to the dose-response model, and 
LQIDYRXURIWKH³good enough lHYHO´*(/PRGHO%Drkham et al., 1996). 
In direct contrast, Stulz et al. (2013) found a positive relationship between duration of 
therapy and RCSI across 20 UCCs, 4 primary care facilities and 2 private mental health centres 
in the UK. With all studies using outcome measures designed to consider well-being, 
symptoms and functioning, there appears to be some inconsistency in the overall relationship 
between total dosage and RCSI rates. These inconsistencies may result from the limitations of 
these descriptive methods, which fail to adjust for potential covariates including diagnoses, 
therapy types, and initial symptom severity. Where studies were marked by similar patient 
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characteristics and therapies (e.g. Delgadillo et al., 2014, 2016) much more consistent findings 
were observed. 
Multilevel modelling and latent growth curve modelling. A total of eight studies used 
multilevel modelling techniques (MLM) and one study used latent growth curve modelling 
(LGCM). One study was specifically focused on CBT for psychotic disorders (Lincoln et al., 
2016).  Of the 8 remaining studies, seven used data primarily from UCCs, and the eighth used 
a sample from both a primary care service and a psychiatric outpatient clinic. All eight studies 
included poly-symptomatic samples and a mixture of therapeutic approaches. Results indicated 
that 15 sessions were necessary for 50% of cases to respond to treatment, with diminishing 
improvements beyond 25 sessions. 
Trajectory and shape of change. Statistical modelling techniques were used in eight 
studies to examine if the characteristic log-linear shape of change is found consistently when 
studying the dose-response effect. Of these, seven studies used longitudinal MLM and 
compared the model fit for different functions of time (number of sessions). Models with a log-
linear function of sessions were found to offer a significantly better fit than a linear function of 
sessions in three studies (Owen et al., 2016; Sembill et al., 2017; Stulz et al., 2013). Other 
studies supported cubic functions of sessions (Baldwin et al., 2009; Erekson et al., 2015; 
Falkenstrom et al., 2016; Reese et al., 2011). In addition, neither Sembill et al. (2017) nor Stulz 
et al. (2013) compared log-linear functions with cubic, therefore superiority of log-linear over 
cubic functions cannot be assumed in these studies, whereas Baldwin et al. (2009) and 
Falkenstrom et al. (2016) did make this comparison and found support for the latter in UCC 
and primary care samples.  In addition, Owen et al. (2015) used multilevel growth mixture 
modelling to examine different clusters of patients who appeared to have distinct trajectories 
of change over the course of therapy. Three latent classes were extracted from the session-by-
session data collected from 10,854 patients primarily taken from UCC databases. Whilst three 
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classes were found, class 1 accounted for 75.3% of patients. These patients were typically 
moderately functioning at the start of treatment and showed initial good response to therapy 
until around session 5. This was followed by a plateau until around session 11, and then a 
subsequent phase of improvement. The described trajectory is similar in nature to a cubic 
function (rather than a log-linear function).  However, these models use intensive time-series 
(session-by-session) data and examine the shape of change within-subjects. This is a different 
analytical approach to typical dose-response curves which compare rates of change between-
subjects that are grouped according to their total treatment duration.  
Dose-effect vs GEL models. MLM was used in five studies to compare the dose-effect 
versus the GEL model, and one used LGCM (Stulz et al., 2013). Of these, four studies (Baldwin 
et al., 2009; Falkenstrom et al., 2016; Owen et al., 2016; Reese et al., 2011) compared fit indices 
of an aggregate (dose-response) model versus a stratified (GEL) model to test this hypothesis. 
In the aggregate model, model improvement is assessed by adding only the fixed effect of 
sessions (or a function of sessions), measured on a session-by-session basis. In this model, all 
patients are assumed to improve at an equivalent rate. In contrast, the individual¶s total dose is 
entered as an additional factor in the stratified model, allowing the rate of change to vary by 
treatment duration. All six studies unanimously found that patients attending different overall 
lengths of therapy change at different rates, supporting the GEL model. There is a clear trend 
among these studies for patients that receive lower doses to be characterised by faster rates of 
improvement.  
Examination of session frequency. MLM with frequency of sessions as a fixed effect 
was used in two studies, in order to examine the impact of session frequency on speed of 
recovery (Erekson et al., 2015; Reese et al., 2011).  Both studies found the fixed effect of 
session frequency to significantly improve model fit. In addition, Erekson et al. (2015) found 
that patients attending weekly therapy were significantly more likely to achieve RC and RCSI 
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sooner than the fortnightly group. Given this evidence, frequency of sessions could be 
suggested to yield important implications for the dose-response effect, or more importantly for 
research purposes, may confound results where this is not accounted for.  
Is there an optimal dose in routine treatment settings? 
Optimal doses for individual studies are presented in Table 1.  Across all studies, estimates of 
the optimal dose ranged between 4 ± 54 sessions. Excluding studies with samples characterised 
by particularly chronic or psychotic symptoms (Asay et al., 2002; Lincoln et al., 2016), between 
4 ± 24 sessions were then estimated.  
University counselling centres (UCCs). Of the 14 studies conducted in UCCs, 12 
suggested an optimal dose. This was defined in 2 ways; firstly on the basis of 50% of the sample 
reaching RC or RCSI (Anderson & Lambert, 2001; Carr et al., 2017; Erekson et al., 2015; 
Harnett et al., 2010; Snell et al, 2001; Wolgast et al., 2003), and secondly on the basis of the 
number of sessions at which diminishing gains were observed (Baldwin et al., 2009; Callahan 
& Hynan, 2005; Draper et al., 2002; Kadera, Lambert, & Andrews, 1996; Kopta et al., 2014; 
Lincoln et al., 2016; Snell et al., 2001). For the former approach, the number of sessions 
required to reach 50% RC ranged between 7 ± 14 sessions and between 11 ± 19 sessions to 
attain 50% RCSI. For the latter approach, the optimal dose ranged between 4 ± 30 sessions. If 
this is estimated excluding cases with psychosis (Lincoln et al., 2016), then the upper boundary 
is 24 sessions.  However, even with the same data set, Snell et al. (2001) suggest different 
outcomes according to these 2 approaches: 8 ± 12 sessions were suggested on the basis of 
diminishing gains for RC and RCSI, however survival analyses on the same data suggested 
that 16 sessions would be required for 50% of the sample to achieve RCSI. Whilst these two 
findings are not mutually exclusive, it highlights some of the reasons for the disparity in 
findings across studies. Overall, the optimal dose across studies in UCCs appears to range 
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between 4 ± 24 sessions for those with common mental health problems, although up to 30 
sessions may be indicated for cases with more severe mental health problems (e.g., psychosis). 
Primary Care services. Five studies examined primary care samples. Two studies 
focused specifically on ³low intensity´ psychological therapies (guided self-help based on 
principles of cognitive behavioural therapy) for depression and anxiety (Delgadillo et al., 2014, 
2016). Both studies recommended an optimal dose between 4 ± 6 sessions; based on the 
observation that at least 4 sessions are necessary for 50% of cases to attain RCSI and 
diminishing RCSI rates were observed in treatments longer than 6 sessions.  Unlike many 
studies included in this review, highly structured, standardised and protocol-driven 
interventions were used in both of these studies. In contrast, Stiles et al. (2008, 2015) and 
Falkenstrom et al. (2016) studied a poly-symptomatic sample receiving a mixture of ³high 
intensity´ psychotherapies (e.g., person-centred, psychodynamic, cognitive behavioural-
therapy), and looked for trends across a greater total number of sessions. Stiles et al. (2008, 
2015) found a trend for diminishing RCSI rates with lengthier therapies, but did not 
recommend an optimal dose. Using session-by-session change scores, Falkenstrom et al. 
(2016) observed greater RCSI in lengthier therapies up to 13 sessions, after which further gains 
diminished.  Overall, primary care populations with mild-to-moderate depression and anxiety 
symptoms require between 4 ± 6 sessions of low intensity guided self-help. Poly-symptomatic 
primary care populations with more severe symptoms may require up to 13 sessions to attain 
RCSI. 
Psychiatric outpatients, eating disorder and patients with intellectual disabilities. 
Falkenstrom et al., (2016) found similar outcomes across psychiatric outpatients regardless of 
their overall treatment length, indicating no dose-response association in this population.  Bell 
et al. (2016) found no association between treatment duration and pre-post therapy change 
scores on the EDE-Q, when adjusted for rapid response (by session 8), in a specialist eating 
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disorders service. Beail et al., (2007) found no differences in treatment responses were 
observed between patients with intellectual disabilities who received a total of 8, 16 or 24 or 
more sessions of psychodynamic psychotherapy. To date, there is scarce and inconclusive 
evidence of a dose-response effect in clinical samples with chronic and/or severe disorders 
(e.g., psychiatric outpatients), patients with eating disorders, and patients with intellectual 
disabilities. 
Discussion 
Main findings 
With few exceptions, we found replicated and consistent support for the observation of a 
curvilinear relationship between the number of sessions and the probability of response to 
treatment, illustrating a trend of diminishing gains with extended treatment. This trend was 
evident across multiple studies in university counselling centres, outpatient psychotherapy and 
primary care settings, and across studies of between-subject comparisons and studies that 
model within-subject trajectories of change. Studies investigating subgroups of patients with 
differential response trajectories have identified some cases that follow a linear trend of 
improvement (e.g., see Owen et al., 2015), although such cases are less prevalent (<20%). We 
also found consistent support for the GEL model assumption that different subgroups of 
patients show different rates of improvement, suggesting that the duration of treatment is 
reflective of therapeutic responsiveness. Whilst the GEL and dose-response models may appear 
contradictory, their implications may not be as mutually exclusive as has been implied in the 
literature. At an individual level, it is clear that some patients have a rapid response to therapy, 
whereas others require longer treatments to attain remission of symptoms. However, seen from 
a population perspective, it is rare to observe cases that attain clinically significant 
improvements in less than 4 sessions. For example, studies with the briefest dose-response 
recommendations for psycho-educational interventions in primary care reported than less than 
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10% of cases overall attained remission of symptoms in treatments with shorter durations than 
4 sessions (e.g., Delgadillo et al., 2016). Studies that examine the point at which 75% of cases 
respond to treatment equally indicate that the probability of response (<25%) to treatment 
beyond 26 sessions is small (e.g., Howard et al., 1986). Hence, both perspectives are valid: 
patients with different needs (e.g., levels of severity or impairment) use a differential number 
of sessions necessary to improve, but usually within predictable boundaries which can be 
referred to as an optimal dose. 
In general, patients with common mental health problems who respond to psychological 
WUHDWPHQWIDOOZLWKLQWZRGLVWLQFWLYH³rapid UHVSRQVH´DQG³gradual UHVSRQVH´JURXSV Rapid 
responders show signs of improvement by session 4, and gradual responders may need up to 
26 sessions to attain reliable and clinically significant improvement. The probability of 
improvement considerably diminishes with lengthier interventions, and therefore patients that 
have not shown reliable improvement by session 26 are statistically more likely to be non-
responders. These optimal dose parameters were found to vary according to the severity of 
clinical problems and intensity of treatments. For example, the optimal dose for patients with 
mild-to-moderate depression and anxiety problems accessing low intensity treatments has been 
found to be between 4 ± 6 sessions; whereas poly-symptomatic clinical samples with varying 
levels of severity accessing high intensity treatments require between 4 ± 26 sessions.  
A weekly therapy schedule has been found to accelerate the course of improvement by 
comparison to a fortnightly treatment schedule (Erekson et al., 2015). This finding fits with 
meta-analytic evidence that more frequent treatment schedules (e.g., twice per week vs. once 
per week) are more effective for the treatment of depression (Cuijpers, Huibers, Ebert, Koole, 
& Andersson, 2013). It is also evident that the necessary dose of treatment varies according to 
the outcomes of interest; requiring relatively short treatments for 50% response in acute 
symptoms and longer treatments for improvements in functioning and characterological 
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problems (Kopta et al., 1994). However, we note that the latter finding is supported by a single 
study. Further research is required to confirm the replicability and generalisability of findings 
about the frequency of sessions and change across different outcome domains. 
Exceptions to these general optimal dose parameters were found for cases with more 
chronic and/or severe psychopathology. Some have recommended up to 30 sessions for 
patients with psychotic disorders (Lincoln et al., 2016). However, there is mixed and 
inconclusive empirical support for the efficacy of psychotherapy for psychotic disorders in 
general, with some meta-analyses indicating small effects compared to control groups (Jauhar 
et al., 2014) and others suggesting no significant effects (e.g., Laws, Darlington, Kondel, 
McKenna, & Jauhar, 2018). If psychotherapy should exert small effects (e.g., ~ g = 0.33 in 
Jauhar et al., 2014), the equivalent response rate would be ~17%, and applying the conventional 
50% dose-response criterion seems meaningless in this context. Furthermore, no evidence to 
support the dose-response effect was found in clinical samples of patients with eating disorders 
(Bell et al., 2016) or those with intellectual disabilities (Beail et al., 2007). Studies in these 
specific populations converge on the observation that most responders tend to be identified 
within the first 8 weeks of therapy, and there is little or no evidence that extended therapy will 
be effective for those who have not shown reliable improvement early on.  
In general, there was little evidence to support long-term psychotherapies beyond 30 
sessions; and this specific dose-response estimate is for cases with psychotic disorders. The 
only study that suggested a dose-response effect with an upper boundary of 54 sessions (Asay 
et al., 2002) was highly atypical, since it analysed cases treated by a single therapist using 
psychodynamic and integrative therapy. Numerous studies applying psychodynamic and 
integrative approaches aggregating results across multiple therapists proposed considerably 
lower optimal dose parameters with an upper boundary of 16 sessions (Erekson et al., 2015; 
Falkenstrom et al., 2016; Harnett et al., 2010; Kadera et al., 1996; Kopta et al., 1994; Wolgast 
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et al., 2003). Like the study by Asay et al (2012), some of these studies offered time unlimited 
therapies (e.g., Anderson & Lambert, 2001) but still observed optimal doses within a relatively 
short treatment duration when results were aggregated over multiple therapists. Overall, it is 
important to note that most of the reviewed evidence is from university counselling centres and 
outpatient psychotherapy clinics for common mental health problems. Many such clinics 
impose limits on treatment duration, which may constrain the results on the dose-response 
effect. There is still scarce and inconclusive evidence concerning the relation between 
treatment duration and outcomes in severe and chronic mental disorders. 
Methodological limitations 
A number of limitations should be considered when interpreting the results of this review. 
Firstly, studies included in the review did not include randomization or control groups. We 
cannot therefore assert a cause-effect relationship between therapy dose and clinical outcomes. 
We can only discern that there is apparently a maximum time period within which remission 
events are observed (these events may be due to psychotherapy or other factors that promote 
natural remission). We sought to particularly examine the dose-response effect in routine 
practice settings because therapies are typically of varying durations and include diverse client 
groups, thus offering insights that are externally valid to ordinary healthcare populations.  
Some studies were excluded from the review as a result of no age range being reported 
(as per exclusion criteria defined a priori).  Many studies demonstrated relatively low quality 
scores. Only 5 studies were found to adequately adjust for all potential confounding factors 
and many studies did not report the presenting problems/diagnoses and types of 
psychotherapies delivered.  In particular, little or no information was available in most studies 
to discern the extent to which concurrent pharmacological treatment may or may not influence 
the results of dose-response analyses. Many studies (n=18) also failed to adequately follow-up 
participants and this included identifying any differences between completers and non-
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completers of therapy, between censored and non-censored cases in survival analyses or 
between patients included and excluded in studies when archival data was used. As shown in 
Table 1, most studies have focused on identifying the point at which 50% of cases respond to 
treatment, but few have reported the number of sessions required to observe higher (e.g., 75% 
or 95%) proportions of responders. 
Whilst this review has revealed the dose of psychotherapy necessary to enable initial 
remission of symptoms, the evidence base regarding the longer-term durability of that change 
is paltry. This may reflect the funding arrangements for routine services; they are 
commissioned to provide treatment and this does not usually involve longer-term follow-up to 
examine relapse or recurrence after treatment.  In addition, several studies (n=18) were 
considered to be limited in generalizability on account of all or most of the sample being treated 
by trainee therapists.    
We also note that most reviewed studies conceptualise the dose-response on the basis 
of symptom reduction. Whilst symptom-reduction as an important target for psychotherapy, 
we still know relatively little about the potential influence of treatment duration on other 
outcomes such as prevention of self-harm or suicidality, occupational functioning or impact on 
WKHSHUVRQ¶VZLGHUIDPLO\DQGVRFLDOIXQFWLRQLQJ 
Recommendations for research 
Future studies could attempt to study the dose-response effect in diagnostically homogeneous 
clinical samples, or by identifying optimal dose parameters for specific protocol-driven 
therapies, adjusted by initial symptom severity and demographic characteristics, alongside 
number of sessions. Introducing specificity in this manner could help to elucidate some 
inconsistencies in the current evidence base and to develop more fine-grained dose-response 
expectations that could inform treatment planning (e.g., for different common mental disorders 
and evidence-based interventions).  It is suggested that survival analysis with cox regression, 
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adjusting for covariates of interest, is a particularly appropriate method to identify optimal 
doses. Researchers using this method tend to report the estimated number of sessions required 
for 50% of patients to attain improvement, however it is also important to identify the point at 
which diminishing gains are observed. We would recommend that the upper boundary could 
be identified at the 95% percentile using Kaplan-Meier curves, thus indicating the point after 
which a negligible (<5%) probability of improvement is expected with additional sessions. 
Furthermore, we argue that the strictest definition of improvement (RCSI, rather than reliable 
change) is necessary to yield optimal dose recommendations that aim to achieve full remission 
of symptoms. As previously noted, long-term follow analyses would add considerable value to 
the dose-response evidence base.  
Implications for policy and practice 
Notwithstanding the heterogeneity of the reviewed studies, discernible patterns of findings in 
the dose-response literature are evident, with important implications for clinical practice. It is 
clear that remission of symptoms is rarely observed in extremely brief treatments, and therefore 
it is recommended that psychological therapy services offer at least 4 sessions as a minimally 
acceptable dose of treatment. Specifically, in low-intensity guided self-help (GSH) 
interventions for mild-to-moderate conditions, session 4 is a key point to formally review 
progress and to address potential obstacles to improvement, since little improvement is 
typically observed after 6 sessions in this treatment model. Non-responders to GSH after 6 
sessions should be referred to more intensive psychotherapies as recommended by clinical 
guidelines (National Institute for Health and Clinical Excellence, 2011); and extending the 
duration of GSH beyond 6 sessions should be limited to cases that show signs of reliable 
improvement. In more conventional psychotherapies including moderate-to-severe cases, 
session 8 tends to mark the point at which the bulk of symptomatic improvement is observed, 
and therefore a formal review of progress is advisable. At this review point, potential 
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difficulties in therapy or obstacles to improvement could be assessed for cases that have not 
yet shown signs of reliable improvement. Adjusting therapy to address potential obstacles to 
improvement (e.g., motivation to change, non-compliance with therapeutic strategies, 
therapeutic alliance deficits, social support deficits, etc.) may be necessary for a trial period 
(e.g., up to 26 sessions to allow the identification of the majority of treatment responders). The 
evidence for longer-term treatments is still inconclusive, and the quality of reviewed studies 
was moderate, so future research is necessary to provide more decisive guidelines on the 
circumstances when longer-term psychotherapy may be indicated. In practice, decisions about 
extending treatment should not only be based on the probability of symptomatic improvements, 
but also considerations related to potential risks to self or to others. 
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Figure 1. Linear versus non-linear change models 
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Figure 2. PRISMA Diagram 
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Table 1. Characteristics of studies included in the review 
 
Article Sample size Patient 
demographics 
Symptoms and 
diagnoses 
Interventions Setting Outcome 
measures 
How was dose-
response studied? 
Findings on dose-response Optimal 
dose 
Quality 
Score 
Anderson & 
Lambert 
(2001) 
N= 75 18-52 (M=30) 
65.3% female, 
34.7% male 
 
 
Mixed  Mixture of low-cost, 
time unlimited 
services. Therapist 
orientations described 
as eclectic. 
University 
training clinic, 
USA.  
OQ-45 Kaplan Meier 
Survival Analysis 
 
8 sessions for 50% to RC  
11 sessions for 50% to RCSI  
 
8-111 9 
Asay et al., 
(2002) 
N= 29 (adult 
sample only 
reported 
here) 
Adults 19+.  
No demographics 
provided.  
Mixed Primarily 
psychodynamic, 
integrated with other 
approaches. 
Private 
practice, USA. 
OQ-45  Kaplan Meier 
Survival Analysis 
with Cox regression 
42 sessions for 50% to RC 
54 sessions for 50% to RCSI 
 
 
42-541 7 
Baldwin et al., 
(2009) 
N=4676 17-60 (M=22.3) 
62% female. 
 
Mixed Individual therapy  Archival 
dataset from 
University 
counselling 
service, USA. 
OQ-45 Multilevel 
modelling  
 
Logistic regression  
 
 
Shape of change best modelled 
by a cubic function of sessions. 
 
Dose effect model: in early 
therapy there is a rapid rate of 
change and this flattens between 
8 and 10 sessions.  
 
However better fit in stratified 
model in favour of GEL model. 
 
Logistic regression suggests 
increase in probability of 
achieving RCSI until 8 sessions.   
 
 
8-102 10 
Beail et al., 
(2007) 
N= 20 17-48 (M=29.3) 
15% female, 85% 
male. 
All patients 
presented with 
intellectual 
disability.  
Therapy was for a 
mixture of 
psychological 
symptoms.  
Psychodynamic 
psychotherapy 
Service for 
people with 
intellectual 
disabilities, 
UK 
SCL-90-R, 
IIP-32, 
Rosenberg 
Self-Esteem 
Inventory 
ANOVA  No differences in treatment 
responses between 8, 16 and 
24+ sessions.  
 
8 sessions is sufficient to 
observe no further gains. 
 
Study suggests this supports the 
dose-response model. 
82 6 
  
Bell et al., 
(2016) 
N=164 18-60 (M=30.13) 
95.1% female 
Eating disorders 
 
Integrative 
psychotherapy 
(41.5%), cognitive 
behavioural therapy 
(18.3%), person 
centered counselling 
(12.2%), cognitive 
analytic therapy 
(12.2%), gestalt 
therapy (11.6%) and 
EMDR (4.3%)  
Outpatient 
psychological 
care service 
for eating 
disorders, UK. 
EDE-Q  MANOVA  No association found between 
treatment duration and outcome 
on EDE-Q when adjusted for 
rapid response early in 
treatment.  
No 
association 
11 
Callahan & 
Hynan, (2005) 
N=61 18-55 (M=29.6) 
52% female 
 
Mixed Not stated University 
training centre, 
USA.  
 
OQ-45 
 
Percentages of 
patients recovering 
(includes both 
RC/RCSI in the 
same outcome 
category). 
**Responsiveness appears to 
diminish around 24 sessions 
 
In 26 sessions, 31% recovered. 
  
Did not reach 50% recovered 
within the 52 session duration 
examined. 
 
242 7 
Carr et al., 
(2017) 
N=132 18+ years (M=30) 
60.3% female 
 
Mixed Individual therapy 
only 
 
Training 
clinic, USA.  
OQ-45 
 
Kaplan Meier 
Survival Analysis 
with number of 
PHQ factors 
entered as a factor. 
 
7 sessions for 50% to RC 
19 sessions for 50% to RCSI 
 
This differed by number of 
PHQ diagnoses. 
7-191 7 
Delgadillo et 
al., (2016) 
N=4451 16-89 (M=42.94) 
63.1% female 
 
Anxiety and 
depression related 
symptoms 
 
Low intensity stress 
control group therapy 
5 IAPT 
centres, UK. 
PHQ-9, 
GAD-7  
Percentages of 
patients achieving 
RCSI 
 
Greatest gains first observed at 
4 sessions with diminishing 
gains beyond 6 sessions 
4-62 11 
Delgadillo et 
al., (2014) 
N=1850  
  
16-87 (M=37.85) 
65% female, 35% 
male 
 
Anxiety and 
depression related 
symptoms 
 
Low intensity 
therapies delivered in 
routine care on the 
IAPT programme. 
IAPT service, 
UK.  
PHQ-9, 
GAD-7 
Percentages of 
patients achieving 
RCSI 
 
 
Minimum of 4 sessions for 50% 
RCSI  
 
Diminishing gains beyond 6 
sessions 
4-62 10 
Draper et al., 
(2002) 
N=1698 
 
*Mean age=23.1 
(SD=5.6) 
66.5%  female 
33.5% male 
Not stated.  
 
 
 
 
 
 
 
 
 
 
95% of centres 
included used a brief 
(10 session) model of 
therapy. 
 
42 universities 
and 9 private 
institutions (all 
higher 
education 
facilities), 
USA. 
 
OQ-45  
 
Percentage of 
patients improved 
(includes both 
RCSI and RC in a 
combined category) 
Peaks in improvement rates at 
sessions 4, 6 and 10. 
 
Minimum number of sessions 
suggested is 4, however 49.5% 
improved at 6 sessions and most 
improvement observed at 
session 10 (54.5% improved).  
4-103 5 
  
Erekson et al., 
(2015) 
N= 21488  
 
*Mean age= 22.5 
54.9% female, 
39.8% male, 5.3% 
unspecified. 
 
Mixed 
 
Individual therapy 
only. Types of 
therapy delivered 
guided by therapist 
orientations, but 
included cognitive± 
behavioural, 
psychodynamic, 
client-centred, 
existential, systems, 
and integrative 
modalities  
 
University 
counselling 
centre, USA.  
OQ-45 Multilevel 
modelling  
 
Multilevel cox 
regression 
 
Multilevel logistic 
regression  
 
 
Cubic modelling of sessions 
provides best fit to the data.  
 
Total dose significantly 
improves model fit, supporting 
GEL over dose-effect. 
 
Faster recovery is achieved in 
once weekly rather than 
fortnightly therapy. RCSI is 
equally likely in both weekly 
and fortnightly groups. 
 
Increased session efficacy if 
dosage received once a week, 
with 50% achieving RC in 8 
sessions.  
 
 
81 8 
Falkenstrom et 
al., (2016) 
Primary care 
sample: 
N=640 
Psychiatric 
outpatient 
sample: 
N=284 
 
Primary care 
sample: 16-88 
(m=36.8), 55.9% 
female , 18% male, 
remaining data 
missing 
Psychiatric 
outpatient 
sample:16-64 
(M=32.6), 36.1% 
male, 33.3% female, 
remaining data 
missing 
 
Mixed. 
Psychiatric 
sample presented 
with more severe 
symptoms. 
Primary care sample: 
Individual therapies 
including supportive 
(30%), 
psychodynamic 
(24%), CBT (18%), 
crisis intervention 
(15%), cognitive 
(15%), behavioural 
(9%), relational (9%), 
existential (7%), 
systemic (7%), and 
interpersonal (6%)  
Psychiatric outpatient 
sample: CBT (48%), 
psychodynamic 
(44%), supportive 
therapy (37%), 
relapse prevention 
(29%), and 
Motivational 
Interviewing (28%). 
As in the primary care 
sample, many 
therapists reported 
more than one 
orientation for a 
single therapy.  
Community 
based primary 
care setting 
and adult 
psychiatric 
outpatient 
clinic, 
Sweden. 
 
CORE-OM  
 
Multilevel 
modelling  
 
 
 
Cubic modelling of sessions 
provides best fit to the data in 
primary care sample only.  
 
From the aggregate model, 
additional benefits observed 
between 8-13 sessions in 
primary care sample. Linear 
improvement observed in 
psychiatric sample. 
 
Faster rates of recovery 
observed in patients attending 
fewer sessions, supporting GEL 
model. 
 
Slower overall recovery rates in 
psychiatric sample. 
 
Primary care sample improved 
more than psychiatric sample.  
 
8-134 9 
  
Harnett et al., 
(2010) 
N=125 
 
18-65 (M= 34.5 ) 
65% female, 35% 
male. 
 
Mixed 
 
Therapist orientations 
varied but included 
cognitive behavioural, 
interpersonal, and 
psychodynamic.  
2 university 
training 
clinics, 
Australia.  
OQ-45 
 
Kaplan-Meier 
Survival Analysis 
10 sessions for 50.6% to RC 
14 sessions for 50% to RCSI 
 
 
 
  
10-141 7 
Kadera et al., 
(1996) 
N=64 
 
All adults 
 (M=28-33)  
Males (31%), 
females (69%)  
 
Mixed 
 
Cognitive 
behavioural, 
humanistic-
existential, 
psychodynamic 
interpersonal, 
integrative-eclectic.  
 
University 
training 
facility, USA. 
OQ-45 
  
Percentage of 
patients who reach 
RCSI at different 
dosages.  
 
Recovery tables, 
based on survival 
analysis  
 
Of 21 patients who did reach 
RCSI:  
8 sessions for 43% RCSI 
13 sessions for 76% RCSI 
 
**Observation of the dose-
effect curve presented in the 
study suggests around 10 
sessions for 50% RCSI 
 
Estimates for the dysfunctional 
sample based on recovery 
tables: 
13 sessions for 44% RCSI 
16 sessions for 50% RCSI 
 
10-161 
 
 
8 
Kopta et al., 
(1994) 
N=854  18+ (M=28-39) 
68-74% female 
across the 5 sites 
Mixed 
 
Therapist orientations 
included 
psychodynamic, 
eclectic, and other e.g. 
cognitive-behavioural, 
client centred.  
 
5 mental 
health centres 
delivering 
psychotherapy, 
USA. 
 
SCL-90-R  Probit analysis 
 
Median effective dose for RCSI: 
5 sessions for acute symptoms 
14 sessions for chronic 
symptoms 
>52 sessions for 
characterological symptoms 
11 sessions for most common 
symptoms 
 
111 10 
Kopta et al., 
(2014) 
N=13,803 18+ 
62.5% female, 
35.3% male 
 
Not stated 
 
 
Therapists varied in 
orientation and 
approach. 
 
 
23 university 
counselling 
centres, USA. 
BHM-20 with 
Suicide 
Monitoring 
Scale 
Percentage of 
patients who reach 
RC as different 
dosages.  
 
Chi square analyses  
 
ANOVA  
Change scores significantly 
greater at 7-10 sessions, with 
diminishing gains beyond this 
point.  
 
Percentage RC significantly 
greater at 7-10 sessions, with no 
significantly greater gains 
beyond this.  
 
7-102 6 
Lincoln et al., 
(2016) 
N=58 
 
18-65 (M=35.67) 
40% female, 60% 
male 
 
All patients 
presented with 
psychosis 
 
45 session model of 
CBT for psychosis 
 
Outpatient 
clinic of a 
psychology 
department, 
Germany.  
CAPE, SCL-
27plus, 
CHOICE 
 
Linear Multilevel 
modelling 
 
Multilevel logistic 
regression   
First significant reduction in 
scores at 15 sessions, with 
minimal gains beyond 25. 
 
Corroborated on the whole by 
CS rates measured on 2 
outcome scales. 
25-302 11 
  
 
Diminishing gains between 20 
and 30 sessions. 
 
 
Owen et al., 
(2016) 
N= 13,664 *Adults  
65.4% female, 
31.2% male, 3.4% 
not reported.  
Not collected. Not stated. 46/47 
University 
counselling 
centres, 1 
other, USA.  
BHM-20 
 
Multilevel 
modelling 
 
 
Log-linear modelling of 
sessions provides best fit to the 
data, except for the life-
functioning subscale, which was 
best represented by a quadratic 
function. 
 
Models including fixed effect of 
total dose and interactions 
consistently out-perform dose-
effect aggregate models. 
Supports GEL model. 
 
n/a 6 
Owen et al 
(2015) 
N= 10854 *Adults  
61.8% female, 
31.5% male, 6.7%  
not reported.  
Not collected. Not stated. 46 University 
counselling 
centres and 1 
community 
outpatient 
setting, USA. 
BHM-20  Multilevel growth 
mixture modelling  
3 latent classes of patients with 
different change trajectories: 
worse before better, slow and 
steady and early and late 
responders.  
 
7KHµHDUO\DQGODWHFKDQJH¶
class represented over 75% of 
the sample. Within this group, 
patients needed to remain in 
therapy for a minimum of 11 
sessions to benefit from the 
second period of improvement. 
 
11+4 6 
Reese et al., 
(2011) 
N=1207 17.64-63.69 
(M=23.72)  
69.7% female  
 
Mixed Cognitive 
behavioural, solution 
focused, 
psychodynamic, 
interpersonal process, 
narrative. Mostly a 
combination. 
University 
counselling 
centre, USA.  
OQ-45 Multilevel 
modelling 
 
 
 
Linear modelling of sessions 
provides best fit to the data 
based on visual inspection of 
the data. 
 
Including total dose of therapy 
in the model significantly 
improved model fit. Supports 
GEL model. 
 
Including session frequency as a 
fixed effect significantly 
improved model fit. Weekly 
better than fortnightly. 
 
n/a 8 
  
Sembill et al., 
(2017) 
N=351 20-75 (M=41.1) 
65.2% female 
Mixed CBT or 
Psychodynamic 
therapy 
University 
outpatient 
clinic, 
Germany 
FEP Multilevel 
modelling  
Log-linear modelling of 
sessions provides best fit to the 
data for the global FEP score.  
 
 
  
n/a 8 
Snell et al., 
(2001) 
N=158 18-60, (M=25.96) 
63% Female, 37% 
male. 
 
Not stated 12 session therapy 
limit.  
University 
counselling 
centre, USA.  
CASPER-
13F, OQ-45 
 
 
Kaplan-Meier 
Survival Analysis 
with Cox regression  
 
Percentage of 
clients to reach RC 
and RCSI 
compared across 
dosage categories 
with chi square 
analyses  
14 sessions for 50% to RC at 10 
month follow up 
16 sessions for 50% to RCSI at 
10 month follow up 
  
Cox regression shows no 
significant effect of pre-test 
scores on CS change but smaller 
dosage required to achieve RC 
if higher pre-test scores are 
observed. 
 
Significantly less patients 
attending 2-7 sessions achieved 
RCSI than patients attending 1 
or 8+ sessions. No differences 
observed for RC in treatment 
lengths. 
 
14-161 
 
8+4 
8 
Stiles et al., 
(2008) 
N=9703 16-99(M=40.9) 
72.4% female 
Mixed Integrative (40.4%), 
person-centred 
(37.0%), 
structured/brief 
(31.4%), cognitive 
behavioural (26.4%), 
supportive (16.8%), 
psychodynamic 
(16.1%). 52.6% 
received a mix. 
 
32 NHS 
primary care 
services, UK.  
CORE-OM Percentage RCSI 
rates correlated 
with total number 
of sessions 
attended. 
 
 
RCSI rates negatively correlated 
with total number of sessions 
(r=-.75).  
 
RC was not significantly 
correlated with total number of 
sessions. 
 
Supports GEL and responsive 
regulation model. 
 
n/a 7 
Stiles et al., 
(2015) 
N=26430 16-95 (m=38.6)  
69.3% female 
Mixed 
 
Integrative (41.2%),  
person-centred 
(36.4%),  
psychodynamic 
(22.8%),  cognitive 
behavioural (14.9%), 
structured/brief 
(14.6%),supportive 
(14%). 41.6% more 
than 1 type of therapy. 
 
 
50 services, 
UK.  
(6 primary 
care services, 
8 secondary, 2 
tertiary, 10 
university 14 
voluntary 8 
workplace and 
2 private 
practices). 
CORE-OM  
 
Percentage RCSI 
rates correlated 
with total number 
of sessions 
attended. 
 
RCSI rates were negatively 
correlated with total number of 
sessions (r=-.58)  
 
RC rates were negatively 
correlated with total number of 
sessions (r=-.40).  
 
Pattern observed in multiple 
sectors but not all.  
 
n/a 9 
  
Supports GEL and responsive 
regulation model. 
 
 
Stulz et al., 
(2013) 
N=6375 18+ 
64% female,  
Not stated Variety of theoretical 
orientations. 
26 centres 
including 20 
college 
counselling 
centres 
(accounting 
for 94% of 
clients), 4 
primary care 
(5.8%), 2 
private 
hospitals 
(0.2%).  
 
 
 
 
 
BHM Multilevel latent 
growth curve 
modelling.  
 
Percentage RCSI 
rates correlated 
with total number 
of sessions 
attended. 
Log-linear modelling of 
sessions provides best fit to the 
data. 
 
Rate of change is faster in 
shorter therapies. This 
corroborates GEL but also dose-
effect as negatively accelerated 
regardless of treatment duration. 
 
Total length of therapy was 
positively correlated with RCSI 
rates. 
n/a 9 
Wolgast et al., 
(2003) 
N=788 18.1=63.6 
(M=23.2), 66.6% 
Female, 33.3% 
male,  
Mixed Individual. Only 20 of 
43 staff listed 
orientations which 
included: 
psychoanalytic, 
psychodynamic, 
integrative (cognitive 
behavioural, 
psychodynamic and 
interpersonal), 
eclectic. 
University 
counselling 
service, USA. 
OQ-45 Kaplan-Meier 
Survival Analysis 
10 sessions for 51% RC 
14 sessions for 51% RCSI 
 
**These session numbers also 
coincide with minimal gains 
beyond these points, from 
observation of survival analysis 
tables. 
10-143 8 
Notes: 
* Indicates adult sample has been assumed  
** Observation interpreted by the author from a graph presented in the study 
RC, statistically reliable change; CS, clinically significant change based on a caseness cut-off; RCSI, reliable and clinically significant change; GEL, Good Enough Level model; OQ-45, Outcome Questionnaire- 45; SCL-90-R, 
Symptom Check-list-90 Revised; IIP-32, Inventory of Interpersonal Problems-32; ANOVA, Analysis of Variance; EDE-Q, Eating Disorders Examination Questionnaire; EMDR, Eye Movement and Desensitisation 
Reprocessing; MANOVA, Multivariate Analysis of Variance; PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalised Anxiety Disorder-7; IAPT, Improving Access to Psychological Therapies programme; CORE-OM, 
Clinical Outcomes in Routine Evaluation- Outcome Measure; CBT, Cognitive Behavioural Therapy; BHM-20, Behavioural Health Measure-20; CAPE, Community Assessment of Psychic Symptoms; SCL-27plus, Symptom 
Checklist- 27 plus; CHOICE, CHoice of Outcome In CBT for psychoses; FEP, German Questionnaire for the Evaluation of Psychotherapeutic Change Processes; CASPER-13F, Computerized Assessment System for 
Psychotherapy Evaluation and Research- follow up, NHS, National Health Service.  
1based on 50% RCSI or RC 
2based on diminishing gains 
3based on a combination of 50% RC or RCSI and diminishing gains 
4based on a minimum to observe additional gains after a plateau 
 
  
Table 2. Summary of outcomes of interest in the included studies. 
 
Outcome event or measures of 
interest 
N Studies 
RCSI at first observed point, 
maintained until termination 
1 Kadera et al., (1996) 
RC, RCSI at first observed point, 
maintained until termination 
4 Anderson & Lambert, (2001) 
Asay et al., (2002) 
Harnett et al., (2010) 
Wolgast et al., (2003) 
RCSI at termination 
5 Baldwin et al., (2009) 
Delgadillo et al., (2014) 
Delgadillo et al., (2016) 
Stiles et al., (2008) 
Stiles et al., (2015) 
RC, RCSI at termination 1 Carr et al., (2017) 
RC, RCSI at 10 month follow-up 1 Snell et al., (2001) 
RC and RCSI combined category 
3 Callahan & Hynan, (2005) 
Draper et al., (2002) 
Kopta et al., (2014) 
RCSI first observation 1 Kopta et al., (1994) 
RC, RCSI first observation 1 Erekson et al., (2015) 
CS at termination 1 Lincoln et al., (2016) 
Pre-post therapy change scores 
3 Beail et al., (2007) 
Bell et al., (2016) 
Kopta et al., (2014) 
Stulz et al., (2013) 
Session-by-session change scores 
7 Baldwin et al., (2009) 
Erekson et al., (2015) 
Falkenstrom et al., (2016)  
Owen et al., (2016) 
Owen et al., (2015) 
Reese et al., (2011) 
Sembill et al., (2017) 
Notes: RC, statistically reliable change; CS, clinically significant change based on a caseness cut-
off; RCSI, reliable and clinically significant improvement. 
 
 
